Literature DB >> 2272287

Interspecies metabolism and pharmacokinetic scaling of theophylline disposition.

F Gaspari1, M Bonati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2272287     DOI： 10.3109/03602539009041084

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  7 in total

1.  Allometric scaling of xenobiotic clearance: uncertainty versus universality.

Authors:  T M Hu; W L Hayton
Journal:  AAPS PharmSci       Date:  2001

2.  Prediction of drug clearance in humans from laboratory animals based on body surface area.

Authors:  X D Liu; J Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

3.  Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches.

Authors:  Kiyomi Ito; J Brian Houston
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

4.  The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans.

Authors:  T Lavé; S Dupin; C Schmitt; B Valles; G Ubeaud; R C Chou; D Jaeck; P Coassolo
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

5.  Interspecies scaling of cimetidine-theophylline pharmacokinetic interaction: interspecies scaling in pharmacokinetic interactions.

Authors:  A R Gascón; B Calvo; R M Hernández; A Domínguez-Gil; J L Pedraz
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

6.  Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.

Authors:  Y Niki; K Itokawa; O Okazaki
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

7.  Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats.

Authors:  A M Maza; A R Gascon; R M Hernandez; M A Solinis; M B Calvo; J L Pedraz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.569
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.